Colin Charnock

Colin Charnock is a Professor of Microbiology at OsloMet's Faculty of Health Sciences, affiliated with the Department of Life Sciences and Health – Pharmacy. He specializes in microbiomes, antibiotic resistance, drug development, and drinking water quality. Charnock holds a joint honors degree in microbiology and biochemistry from King's College London, a master's in molecular biology from the University of Oslo (UiO), and a UiO PhD in molecular systematics of bacteria.

His research focuses on microbial interactions with human health and the built environment, including studies on ocular microbiota in dry eye disease, bacterial components affecting skeletal muscle metabolism, and nanoparticle drug carriers for biofilm infections. He leads projects like 'Sustainable Built Environment (SustainaBuilt)' and 'Smart Development of nano-antibiotics.' Industrial experience includes water quality improvement methodologies.

Key research themes include microbiome analysis (ocular, built environment), antibiotic resistance mechanisms, and nanotechnology-based drug delivery. Charnock has published over 60 peer-reviewed articles, with recent work emphasizing biofilm-targeted therapies and genomic studies of pathogenic bacteria. His collaborative projects explore pharmacist roles in antibiotic stewardship and interprofessional healthcare collaboration.